[go: up one dir, main page]

WO2012061536A3 - Methods for treating hair loss disorders - Google Patents

Methods for treating hair loss disorders Download PDF

Info

Publication number
WO2012061536A3
WO2012061536A3 PCT/US2011/059027 US2011059027W WO2012061536A3 WO 2012061536 A3 WO2012061536 A3 WO 2012061536A3 US 2011059027 W US2011059027 W US 2011059027W WO 2012061536 A3 WO2012061536 A3 WO 2012061536A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
hair loss
treating hair
loss disorders
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/059027
Other languages
French (fr)
Other versions
WO2012061536A2 (en
Inventor
Angela M. Christiano
Raphael Clynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of WO2012061536A2 publication Critical patent/WO2012061536A2/en
Anticipated expiration legal-status Critical
Publication of WO2012061536A3 publication Critical patent/WO2012061536A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

The invention provides for methods for treating a hair loss disorder in a subject by administering a NKG2D inhibitor, IL-15 inhibitor, or a combination thereof.
PCT/US2011/059027 2010-11-02 2011-11-02 Methods for treating hair loss disorders Ceased WO2012061536A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40951410P 2010-11-02 2010-11-02
US61/409,514 2010-11-02

Publications (2)

Publication Number Publication Date
WO2012061536A2 WO2012061536A2 (en) 2012-05-10
WO2012061536A3 true WO2012061536A3 (en) 2014-04-10

Family

ID=46025095

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/059027 Ceased WO2012061536A2 (en) 2010-11-02 2011-11-02 Methods for treating hair loss disorders

Country Status (1)

Country Link
WO (1) WO2012061536A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102993097A (en) * 2012-11-09 2013-03-27 贵州大学 Pyrazole amide compound and application thereof
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
US12459980B2 (en) 2018-07-25 2025-11-04 AskGene Pharma, Inc. IL-21 prodrugs and methods of use thereof
WO2020252264A1 (en) 2019-06-12 2020-12-17 AskGene Pharma, Inc. Novel il-15 prodrugs and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080069791A1 (en) * 2003-12-29 2008-03-20 Universitaetsklinikum Muenster Means for stimulation and activation of hair growth by il-15

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080069791A1 (en) * 2003-12-29 2008-03-20 Universitaetsklinikum Muenster Means for stimulation and activation of hair growth by il-15

Also Published As

Publication number Publication date
WO2012061536A2 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
WO2012061537A3 (en) Methods for treating hair loss disorders
WO2012006538A8 (en) Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
PL2649242T3 (en) Method for building structures, particularly passages under operating railways or the like.
WO2013046060A9 (en) Paper and methods of making paper
WO2014042433A3 (en) Compounds and compositions for modulating adenosine a3 receptor activity
WO2014035140A3 (en) Compounds and compositions for modulating histone methyltransferase activity
WO2012166626A8 (en) Reagents and methods for treating dental disease
WO2013177055A3 (en) ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
WO2011075636A3 (en) Wise binding agents and epitopes
WO2012103393A3 (en) Controlling mealybugs
MY151551A (en) Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors
WO2011133504A3 (en) Nanozymes, methods of making nanozymes, and methods of using nanozymes
WO2012058219A3 (en) Deuterium enriched rasagiline
EP2729464B8 (en) Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors
WO2013023151A3 (en) Compositions and methods for treating celiac sprue disease
WO2011130347A3 (en) Methods for enhancing axonal regeneration
WO2012064743A3 (en) Methods for improving heart function
WO2011083483A3 (en) Method for treatment of inflammatory disease and disorder
WO2012061536A3 (en) Methods for treating hair loss disorders
WO2013016280A3 (en) Compositions and methods for selecting aptamers
WO2012154533A3 (en) Controlling planthoppers
WO2011110624A3 (en) β-HYDROXYALKYLAMIDES, METHOD FOR THEIR PRODUCTION AND USE THEREOF
WO2011133893A3 (en) Cyanide antidotes
WO2012080466A3 (en) Ingenols for treating seborrheic keratosis
WO2011011733A3 (en) Factor replacement therapy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11838770

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 11838770

Country of ref document: EP

Kind code of ref document: A2